SynthesisJournal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine2025
Comparison of side effects of different mandibular advancement devices for patients with obstructive sleep apnea: a systematic review and meta-analysis.
Synthesis in Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Increasing reports and shifting categorical trends in adverse events for oral appliances.Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine · 2026Article
- Mandibular advancement devices in severe obstructive sleep apnea: a second-line option that deserves greater recognition.Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
STUDY
objectivesMandibular advancement devices (MADs) are widely used as noncontinuous positive airway pressure treatment options for obstructive sleep apnea, but they are associated with some side effects. To figure out the side effects related to MAD design and aid clinical decision-making, this systematic review compares the types and severity of side effects caused by both the adjustable and the nonadjustable MADs.
methodsThree databases were searched until May 2024 and 26 relevant studies were eligible for inclusion. The side effects examined include dentoskeletal changes and issues related to the temporomandibular joint, masticatory muscles, or periodontium.
resultsCompared with adjustable MADs (overjet: mean difference [MD]: 0.98, 95% CI: 0.66-1.30; overbite: MD: 0.99, 95% CI: 0.67-1.30), nonadjustable MADs show less change in overjet (MD: 0.88, 95% CI: 0.49-1.28) and overbite (MD: 0.79, 95% CI: 0.32-1.26). Adjustable MADs have less impact on temporomandibular joint and masticatory muscles than nonadjustable MADs. However, there were no significant differences in sella-nasion-A point (MD: 0.10, 95% CI: -0.36 to 0.56), sella-nasion-B point (MD: 0.19, 95% CI: -0.28 to 0.67), or A-nasion-B point (MD: -0.14, 95% CI: -0.42 to 0.15) after treatment of either type of MAD. There were no signs of periodontitis or bone resorption observed after treatment with adjustable MAD.
conclusionsThe findings provide valuable information for clinicians in selecting an appropriate MAD. However, given the limitations of the current evidence, there is no single superior custom MAD design in terms of side effects at present. CITATION: Wang X, Chen H, Ge S, Orhan K, van der Stelt P, Shi X-Q. Comparison of side effects of different mandibular advancement devices for patients with obstructive sleep apnea: a systematic review and meta-analysis.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.